AI assistant
PATRYS LIMITED — Director's Dealing 2025
Oct 27, 2025
65525_rns_2025-10-27_d9746132-19c2-45c5-9908-ce733f07049a.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Name of entity | Patrys Limited |
|---|---|
| ABN | 97 123 055 363 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Peter James Christie |
|---|---|
| Date of last notice | 22 October 2025 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Waterbeach Investments Pty Ltd Family A/C> Mr Peter Christie is a director and beneficiary of the above holder which is the registered holder of the securities. |
| Date of change | 22 October 2025 |
| No. of securities held prior to change | 2,083,333 Fully paid ordinary shares |
| Class | Unlisted options, exercisable at $0.024 each, expiring 30 November 2029 |
| Number acquired | 833,333 unlisted options, exercisable at $0.024 each, expiring 30 November 2029 |
| Number disposed | - |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
Nil – Issue of sub-underwriter options issued as consideration for sub- underwriting the Entitlement Offer. |
|---|---|
| No. of securities held after change | 2,083,333 Fully paid ordinary shares 833,333 unlisted options, exercisable at $0.024 each, expiring 30 November 2029 |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back |
Issue of Sub-underwriter Options following shareholder approval at the Company’s Annual General Meeting held on 9 October 2025, pursuant to Resolution 12. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder (if issued securities) |
N/A |
| Date of change | N/A |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
N/A |
| Interest after change | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No |
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
N/A |
| If prior written clearance was provided, on what date was this provided? |
N/A |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 3
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Name of entity | Patrys Limited |
|---|---|
| ABN | 97 123 055 363 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Anton Uvarov |
|---|---|
| Date of last notice | 22 October 2025 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
N/A |
| Date of change | 22 October 2025 |
| No. of securities held prior to change | 16,666,666 Fully paid ordinary shares |
| Class | - Fully paid ordinary shares - Unlisted options, exercisable at $0.024 each, expiring 30 November 2029 |
| Number acquired | (1) 3,333,333 fully paid ordinary shares (2) 1,666,666 unlisted options, exercisable at $0.024 each, expiring 30 November 2029 (3) 6,666,666 unlisted options, exercisable at $0.024 each, expiring 30 November 2029 |
| Number disposed | - |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
(1) $50,000 (2) Nil - Free attaching unlisted options as part of Tranche 2 Placement. (3) Nil – Issue of sub-underwriter options issued as consideration for sub- underwriting the Entitlement Offer. |
|---|---|
| No. of securities held after change | 19,999,999 Fully paid ordinary shares 8,333,332 unlisted options, exercisable at $0.024 each, expiring 30 November 2029 |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back |
(1) Issue of Tranche 2 Placement Shares following shareholder approval at the Company’s Annual General Meeting held on 9 October 2025, pursuant to Resolution 10. (2) Issue of free attaching Unlisted Options to the Tranche 2 Placement following shareholder approval at the Company’s Annual General Meeting held on 9 October 2025, pursuant to Resolution 10. (3) Issue of Sub-underwriter Options following shareholder approval at the Company’s Annual General Meeting held on 9 October 2025, pursuant to Resolution 11. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder (if issued securities) |
N/A |
| Date of change | N/A |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
N/A |
|---|---|
| Interest after change | N/A |
Part 3 –[+] Closed period
Were the interests in the securities or contracts No detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to N/A allow the trade to proceed during this period? If prior written clearance was provided, on what N/A date was this provided?
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 3
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Name of entity | Patrys Limited |
|---|---|
| ABN | 97 123 055 363 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | James Campbell |
|---|---|
| Date of last notice | 22 October 2025 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct and Indirect | |
|---|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Barrabool Biotechnology Pty Ltd Campbell Family A/C> Dr. Campbell is a beneficiary of the above entity |
|
| Date of change | 22 October 2025 | |
| No. of securities held prior to change | Direct: 2,245,320 Fully paid ordinary shares Indirect: 194,008 Fully paid ordinary shares |
|
| Class | Fully paid ordinary shares | |
| Number acquired | 10,701,795 fully paid ordinary shares | |
| Number disposed | - |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
Deemed issue price of $0.015 per share | |
|---|---|---|
| No. of securities held after change | Direct: 12,947,115 Fully paid ordinary shares Indirect: 194,008 Fully paid ordinary shares |
|
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back |
Issue of Redundancy Shares following shareholder approval at the Company’s Annual General Meeting held on 9 October 2025, pursuant to Resolution 21. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder (if issued securities) |
N/A |
| Date of change | N/A |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
N/A |
| Interest after change | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No |
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
N/A |
| If prior written clearance was provided, on what date was this provided? |
N/A |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 3